{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-25-002045","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.697331+00:00","generated_at":"2026-05-20T02:03:24.019303+00:00","sec_items":["8.01","3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Silexion Therapeutics appeals Nasdaq delisting; hearing set for June 26, 2025","bullets":["Received Nasdaq delisting notice on May 22 for MVLS <$50M and MVPHS <$15M deficiencies.","Requested hearing on May 28, 2025, staying delisting; hearing scheduled June 26, 2025.","Intends to apply to transfer listing to Nasdaq Capital Market under Equity Standard requiring ≥$2.5M shareholders' equity.","No assurance of success; securities continue trading on Nasdaq under SLXN and SLXNW."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-25-002045","json":"https://secwatch.observer/filing/0001178913-25-002045.json","markdown":"https://secwatch.observer/filing/0001178913-25-002045.md","text":"https://secwatch.observer/filing/0001178913-25-002045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/0001178913-25-002045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/zk2533312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:03:24.019303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9113586bbfee18130062225681d1f736ec141b22","claim":"Silexion Therapeutics Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C), 5810(c)(3)(C)).","evidence_excerpt":"Listing Rules 5450(b)(2)(A) and 5450(b)(2)(C), which require a company such as ours whose securities are listed on the Nasdaq Global Market under the “Market Value Standard” to maintain a minimum Market Value of Listed Securities (an “ MVLS ”) of $50,000,000 and a minimum Market Value of Publicly Held Shares (an “ MVPHS ”) of $15,000,000 for continued listing on the Nasdaq Global Market.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002045/0001178913-25-002045-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(A), 5450(b)(2)(C), 5810(c)(3)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}